CG
Column Group Portfolio holdings
AUM
$65.7M
This Quarter Return
-23.01%
1 Year Return
-5.8%
3 Year Return
-15.66%
5 Year Return
–
10 Year Return
–
AUM
$151M
AUM Growth
+$151M
(-42%)
Cap. Flow
-$37.4M
Cap. Flow
% of AUM
-24.86%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Revolution Medicines
RVMD
|
$37.3M |
| 2 |
EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
|
$170K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
RAPT Therapeutics
RAPT
$188M
| $44.6M | 29.58% | 2,680,621 | – | – |
|
|
2
Revolution Medicines
RVMD
$7.1B
| $34.1M | 22.62% | 1,230,641 -1,346,579 | -52% | -$37.3M |
|
3
Tenaya Therapeutics
TNYA
$184M
| $24M | 15.92% | 9,400,290 | – | – |
|
4
Oric Pharmaceuticals
ORIC
$994M
| $21.6M | 14.33% | 3,568,181 | – | – |
|
|
NGM
5
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $19.4M | 12.89% | 18,136,735 | – | – |
|
6
Surrozen
SRZN
$104M
| $4.61M | 3.06% | 9,414,795 | – | – |
|
|
EFTR
7
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $2.42M | 1.6% | 4,026,224 -283,105 | -7% | -$170K |
|